Skip to main content
. 2023 Oct 24;2023(10):CD014967. doi: 10.1002/14651858.CD014967.pub2

CTRI/2016/10/007412.

Study name A clinical study to compare levetiracetam and phenobarbitone in newborns with birth asphyxia
Methods RCT
Participants Term neonates with HIE II/III, age < 24 hours
Interventions PB 20 mg/kg, maintenance vs LEV 20‐60 mg/kg, maintenance
Outcomes Seizure control with 1st‐line drug, need for further ASM, neonatal mortality, adverse events of LEV, duration of hospital stay, neurodevelopment
Starting date 2016
Contact information sha.akht@gmail.com
Notes Calculated sample size 60